Distinguishing between longevity and buffered-deleterious genotypes for exceptional human longevity: the case of the

Derek M Huffman1, Joris Deelen, Kenny Ye

  • 1Department of Medicine, The Albert Einstein College of Medicine of Yeshiva University, New York, NY, USA.

Insights

The MTP CC genotype is linked to human longevity in Ashkenazi Jews, showing a U-shaped pattern with aging. This genotype is beneficial only when buffered by other longevity genes.

Area of Science:

  • Genetics and Aging Research
  • Human Longevity Studies
  • Population Genetics

Background:

  • The MTP gene's single nucleotide polymorphism, rs2866164, has been previously linked to human longevity.
  • However, this association requires further validation in independent longevity studies.
  • Understanding genetic factors influencing extreme longevity is crucial for aging research.

Purpose of the Study:

  • To validate the association of the MTP rs2866164 polymorphism with longevity in an Ashkenazi Jewish population.
  • To investigate the age-specific frequency patterns of the MTP CC genotype.
  • To explore the interaction between the MTP CC genotype and other known longevity-associated genotypes.

Main Methods:

  • Genotyping of the MTP rs2866164 polymorphism in centenarians, their offspring, and control groups.
  • Analysis of MTP CC genotype frequency across different age strata (55-85 years and >90 years).
  • Statistical examination of interactions between the MTP CC genotype and three validated longevity genotypes.

Main Results:

  • The MTP CC genotype was significantly overrepresented in centenarians and their offspring compared to controls.
  • A U-shaped frequency pattern of the MTP CC genotype was observed with aging, declining from 55-85 years and increasing after 90 years.
  • The MTP CC genotype showed a significant buffering effect from three validated longevity genotypes, enhancing its presence in centenarians and improving survivorship.

Conclusions:

  • The MTP CC genotype is identified as a buffered-deleterious genotype, beneficial for longevity only when interacting with other specific longevity genes.
  • Age-specific analysis of genotype frequencies is essential for accurately identifying true longevity-associated variants.
  • This study highlights the complex interplay of genetic factors in determining human extreme longevity.

Related Concept Videos

Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...